Matching geography
Reports matching your search in:
 
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
Region: All Regions > North America
Category: All Categories > Life Sciences > Pharmaceuticals > Manufacturing, Packaging & Detailing
(363 reports matching your criteria)
 
  2    4  5  6  7  8  9  10  
2014 U.S. Pharmaceutical Preparation Mfg. Industry-Capital & Expenses Report
12/15/2013 | published by: Barnes Reports
... report features 2014 current and 2015 forecast estimates on the cost of materials, capital expenditures, inventories, rentals, and other expenses nationally and for all 50 U.S. States and up to 900 metro areas. Expenses categories ...  |  read more...
$149.00
Generic Pharmaceutical Manufacturing in the US - Industry Market Research Report
12/13/2013 | published by: IBISWorld
... healthcare reform will benefit the industry, with more consumers gaining insurance coverage for prescription drugs, improved generic drug approval processes and an established pathway to approval for biosimilars. As in the past five years, manufacturers ...  |  read more...
$1,020.00
Medicinal and Botanical Manufacturing Industry in the U.S. and its International Trade [2013 Q4 Edition]
11/15/2013 | published by: Supplier Relations US, LLC
... and pricing, and trends during the current environment, including the output and shipment changes over the past months. At 173 pages with over 150 charts and tables, the report covers topics such as current macroeconomic ...  |  read more...
$599.00
Pharmaceutical Preparation Manufacturing Industry in the U.S. and its International Trade [2013 Q4 Edition]
11/15/2013 | published by: Supplier Relations US, LLC
... inventory data available through September 2013. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. This 173-page report includes the most recent information on ...  |  read more...
$799.00
Biological Product (except Diagnostic) Manufacturing Industry in the U.S. and its International Trade [2013 Q4 Edition]
11/15/2013 | published by: Supplier Relations US, LLC
... shipment, and inventory data available through September 2013. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. This 168-page report includes the most recent ...  |  read more...
$599.00
U.S. Healthcare BPO Market- Payer (Claims Processing, HR Services, and Finance and Accounts), Provider (Medical Billing and Coding), and Pharmaceutical (Clinical Trials, Contract Manufacturing and Non-Clinical Services)-Trends and Global Forecasts to 2018
8/5/2013 | published by: MarketsandMarkets
... market are: developments and innovation in information technology and regulatory changes. Approximately 75% of U.S. healthcare companies outsource their work to external locations. This is due to the shortage of qualified staff in key positions, ...  |  read more...
$4,650.00
PharmaPoint: Type 2 Diabetes - US Drug Forecast and Market Analysis to 2022
7/31/2013 | published by: GlobalData
... The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more than ...  |  read more...
$4,995.00
The 2013-2018 Outlook for Anemia Drugs in the United States
7/17/2013 | published by: Icon Group International, Inc.
... of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of ...  |  read more...
$495.00
The 2013-2018 Outlook for Animal Feed Antibiotics in the United States
7/17/2013 | published by: Icon Group International, Inc.
... (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state ...  |  read more...
$495.00
The 2013-2018 Outlook for Analgesics (painkillers) in the United States
7/17/2013 | published by: Icon Group International, Inc.
... of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of ...  |  read more...
$495.00
The 2013-2018 Outlook for Anti-Infectives in the United States
7/17/2013 | published by: Icon Group International, Inc.
... dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United ...  |  read more...
$495.00
The 2013-2018 Outlook for Astaxanthin in the United States
7/17/2013 | published by: Icon Group International, Inc.
... dollars), or potential industry earnings (P.I.E.) estimates are given across some 8,000 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United ...  |  read more...
$495.00
The 2013-2018 Outlook for Pharmaceutical Contract Manufacturing (PCM) in the United States
7/17/2013 | published by: Icon Group International, Inc.
... Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of ...  |  read more...
$495.00
The 2013-2018 Outlook for Botulinum Toxin in the United States
7/17/2013 | published by: Icon Group International, Inc.
... of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of ...  |  read more...
$495.00
The 2013-2018 Outlook for Antibacterial Drugs in the United States
7/17/2013 | published by: Icon Group International, Inc.
... of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of ...  |  read more...
$495.00
The 2013-2018 Outlook for Antibiotics in the United States
7/17/2013 | published by: Icon Group International, Inc.
... dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United ...  |  read more...
$495.00
The 2013-2018 Outlook for Anticoagulants in the United States
7/17/2013 | published by: Icon Group International, Inc.
... dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United ...  |  read more...
$495.00
The 2013-2018 Outlook for Anti-Hypertensive Drugs in the United States
7/17/2013 | published by: Icon Group International, Inc.
... of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of ...  |  read more...
$495.00
The 2013-2018 Outlook for Anti-Migraine Drugs in the United States
7/17/2013 | published by: Icon Group International, Inc.
... of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of ...  |  read more...
$495.00
The 2013-2018 Outlook for Anti-Obesity Drugs in the United States
7/17/2013 | published by: Icon Group International, Inc.
... of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of ...  |  read more...
$495.00
The 2013-2018 Outlook for Intravenous (IV) Iron Drugs in the United States
7/17/2013 | published by: Icon Group International, Inc.
... Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of ...  |  read more...
$495.00
The 2013-2018 Outlook for Bisphosphonates in the United States
7/17/2013 | published by: Icon Group International, Inc.
... dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United ...  |  read more...
$495.00
Analgesics - US - July 2013
7/1/2013 | published by: Mintel International Group Ltd.
... be attributed to more people choosing alternative ways to treat their pain. However, the growing market of an aging population bodes well for the market of OTC analgesics, as does the prevalence of people with ...  |  read more...
$3,995.00
2013 U.S. Agricultural products, crude (flowers, grains, etc.) materials used by the Medicinal and botanical manufacturing Industry-Materials & Manufacturing Report
6/15/2013 | published by: Barnes Reports
... report features 2013 current and 2014 forecast estimates on Agricultural products, crude (flowers, grains, etc.) materials used by the Medicinal and botanical manufacturing industry nationally and for all 50 U.S. States and up to 900 ...  |  read more...
$199.00
2013 U.S. Paperboard containers, boxes materials used by the Medicinal and botanical manufacturing Industry-Materials & Manufacturing Report
6/15/2013 | published by: Barnes Reports
... The report features 2013 current and 2014 forecast estimates on Paperboard containers, boxes materials used by the Medicinal and botanical manufacturing industry nationally and for all 50 U.S. States and up to 900 metro areas.  |  read more...
$199.00
  2    4  5  6  7  8  9  10